Literature DB >> 638587

Failure of aspirin to prevent postoperative deep vein thrombosis in patients undergoing total hip replacement.

J D Stamatakis, V V Kakkar, D Lawrence, P G Bentley, D Nairn, V Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 638587      PMCID： PMC1603969          DOI： 10.1136/bmj.1.6119.1031

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis.

Authors:  V V Kakkar
Journal:  Milbank Mem Fund Q       Date:  1972-01

2.  Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery.

Authors:  T H Schöndorf; D Hey
Journal:  Haemostasis       Date:  1976

3.  Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.

Authors:  M Dechavanne; D Ville; J J Viala; A Kher; J Faivre; M B Pousset; H Dejour
Journal:  Haemostasis       Date:  1975
  3 in total
  5 in total

1.  DVT prophylaxis in total hip replacement.

Authors:  T G DeLoughery
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

Review 2.  Prophylaxis of venous thromboembolism.

Authors:  V V Kakkar; M D Stringer
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

Review 3.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

Review 4.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

Review 5.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.